OOIR: Observatory of International Research

Papers

(The median citation count of Endocrine Reviews is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	507
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	290
Endocrine Manifestations and New Developments in Mitochondrial Disease	252
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	229
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	215
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	194
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future	193
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	182
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	178
The Molecular Biology of Midgut Neuroendocrine Neoplasms	176
A critical assessment of fasting to promote metabolic health and longevity	145
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome	135
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	121
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	107
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies	105
Stem Cells and Organs-on-chips: New Promising Technologies for Human Infertility Treatment	95
The Biology and Clinical Implications of PCSK7	93
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	88
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	82
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	81
Post-translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity	80
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	79
Estrogen Receptor Signaling in the Immune System	78
Contemporary Biological Insights and Clinical Management of Craniopharyngioma	71
Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”	65

New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature	64
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	63
Time-restricted Eating for the Prevention and Management of Metabolic Diseases	59
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	59
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	58
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	57
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	57
The Metabolic Role and Therapeutic Potential of the Microbiome	56
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	55
Imaging of Pheochromocytomas and Paragangliomas	55
Adiponectin and Adiponectin Receptors in Atherosclerosis	54
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	49
The Cortisol Awakening Response: Regulation and Functional Significance	46
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	46
Brown Adipose Tissue—A Translational Perspective	46
Molecular and Clinical Spectrum of Primary Hyperparathyroidism	45
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease	44
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications	43
Erratum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	43
G-protein coupled & membrane tyrosine kinase receptors relationship yield therapy opportunities	42
Protective Factors and the Pathogenesis of Complications in Diabetes	40
Endocrine Controls of Skin Aging	40
Medullary Thyroid Cancer: Updates and Challenges	38
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy	38
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease	38
A Modern Approach to Dyslipidemia	38
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification	36
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management	36
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors	35
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?	34
Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency	33
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma	31
The Role of Iodine for Thyroid Function in Lactating Women and Infants	30
Teprotumumab for the Treatment of Thyroid Eye Disease	30
Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma	29
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia	28
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement	27
Update on Adipose Tissue and Cancer	27
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications	26
A Clinical Update on Gestational Diabetes Mellitus	25
Crosstalk Between the Neuroendocrine System and Bone Homeostasis	25
Corrigendum to: The Role of Iodine for Thyroid Function in Lactating Women and Infants	25
The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision	25
Corrigendum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	23
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy	23
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice	22
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens	22
Endocrine Dysfunction in Primary Mitochondrial Diseases	22
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease	20
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome	20

Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications	19
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease	19